Search Results
You are looking at 1 - 1 of 1 items for :
- Author: Marcello R P Markus x
- Thyroid x
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan
Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed
Search for other papers by Giovanni Targher in
Google Scholar
PubMed
Search for other papers by Antje Steveling in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
The associations of thyroid function parameters with non-alcoholic fatty liver disease (NAFLD) and hepatic iron overload are not entirely clear. We have cross-sectionally investigated these associations among 2734 participants of two population-based cross-sectional studies of the Study of Health in Pomerania. Serum levels of thyroid-stimulating hormone (TSH), free tri-iodothyronine (fT3), and free thyroxine (fT4) levels were measured. Liver fat content (by proton-density fat fraction) as well as hepatic iron content (by transverse relaxation rate; R2*) were assessed by quantitative MRI. Thyroid function parameters were associated with hepatic fat and iron contents by median and logistic regression models adjusted for confounding. There were no associations between serum TSH levels and liver fat content, NAFLD, or hepatic iron overload. Serum fT4 levels were inversely associated with liver fat content, NAFLD, hepatic iron contents, and hepatic iron overload. Serum fT3 levels as well as the fT3 to fT4 ratio were positively associated with hepatic fat, NAFLD, hepatic iron contents, but not with hepatic iron overload. Associations between fT3 levels and liver fat content were strongest in obese individuals, in which we also observed an inverse association between TSH levels and NAFLD. These findings might be the result of a higher conversion of fT4 to the biologically active form fT3. Our results suggest that a subclinical hyperthyroid state may be associated with NAFLD, particularly in obese individuals. Furthermore, thyroid hormone levels seem to be more strongly associated with increased liver fat content compared to hepatic iron content.
